Along these lines, in one of the very few examples of a solid tumor targeting NDCs, a cisplatin conjugated biparatopic anti-EGFR nanobody construct fused to anti-Alb was not able to demonstrate comparable tumor remission 66. Here, EGFR is linked to neoplasm.